ArticleTransboundary and emerging diseases2025
Retrospective Study Reveals Decades of PCV4 Circulation in Spain.
Article in Transboundary and emerging diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Beyond labels: current sequencing data do not support standardized porcine circovirus 3 (PCV3) genotypes.BMC veterinary research · 2026Article
- Emerging Challenges and Advances in Porcine Circovirus: A Decade in Review.Transboundary and emerging diseases · 2026Review
- On the origin, evolution, and maintenance of RNA editing.Nucleic acids research · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Porcine circovirus 4 (PCV4) was first identified in China in 2019 and retrospectively traced back to 2008. However, unlike other circoviruses, its distribution appeared to be largely confined to Asian countries until recent reports from Spain and the United States. This study aims to enhance knowledge of the past and present circulation of PCV4 in non-Asian countries, particularly in Spain and in wild boars, where it was previously detected at a significant prevalence. By genetically characterizing the strains, the contextualization within both national and international epidemiological frameworks was attempted. A total of 302 lymph node samples were tested, with 62 testing positives by quantitative real-time polymerase chain reaction (qPCR), predominantly from the 2011 to 2015 period, although five positives were detected in the 2022-2024. Complete open reading frame 2 (ORF2) sequences were obtained from 10 strains. Phylogenetic analysis revealed two major clusters: one comprising only Chinese sequences and another containing strains from multiple continents, including Spain and the United States. The Spanish strains formed a distinct monophyletic clade whose introduction in the country was estimated through phylodynamic analyses around 2000, suggesting long-term undetected circulation. Within Spain, a progressive geographical spread and strain exchange between wild boars and outdoor reared domestic pigs could be inferred. On the other hand, the lack of detection in intensively raised pigs, at least in Europe, remains unclear. The present findings extend the current knowledge of PCV4 history outside Asia and challenge the paradigm of a recent international spreading. Recognizing the current uncertainties in PCV4's international distribution and epidemiology, further efforts are needed, including the use of archived samples in diagnostic activities as well as the sharing of negative results.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.